 |
|
|
With health care reform initiatives, quality measurement, and requirements for much greater accountability to numerous stakeholder groups, new questions arise constantly that need to be answered with more depth and greater insight.
Healthcare companies operate in an industry having truly unique challenges like long product development life cycles, regulated environments of different countries, complex market dynamics, etc. Our reports help these organizations to make informed business decisions in this increasingly challenging business environment.
We specialize in high-level information processing and analysis, specific to the needs of Healthcare and related industries worldwide. These reports contain analytical as well as statistical information on Healthcare industry. We thoroughly analyze new vistas being opened by the strongly growing healthcare industry like Telemedicine, Healthcare IT, Medical Devices, Medical Tourism, Health Insurance, E Health and Hospital Services.
 |
| US e-health Market Analysis |
| Jul, 2011 | Pages : 75 |
| The e-Health adoption and its holistic application in healthcare system will open widespread market opportunities for the sector, which is poised to grow at a CAGR of around 13% during 2010-2015......
read more |
|
Buy Now
US$ 1000.00
|
|
|
|
 |
| Indian Diagnostic Market Analysis |
| Jun, 2011 | Pages : 65 |
| With strong private sector participation, it is expected that by 2012, the Indian diagnostics sector will reach to the mark of INR 156 Billion, growing at a CAGR of around 16% since 2010......
read more |
|
Buy Now
US$ 800.00 500.00
|
|
 |
| Israel Life Sciences Market Analysis |
| Jun, 2011 | Pages : 55 |
| Extensive academic research, government support, rising demand for technological innovations are some of the factors that will fuel growth in the Israeli Life Sciences industry in the coming years......
read more |
|
Buy Now
US$ 800.00 500.00
|
|
 |
| Clinical Trials Market in Russia |
| May, 2011 | Pages : 50 |
| Russian clinical trials market slipped into negative territory with just 500 clinical trials in 2010. However, it is likely to offset in near future as the government is taking necessary steps......
read more |
|
Buy Now
US$ 1000.00 800.00
|
|
 |
| Indian Pharma Sector Forecast 2014 |
| May, 2011 | Pages : 105 |
| The domestic pharmaceutical market is expected to register CAGR of around 15% during FY 2012 - FY 2014 to generate revenue worth around INR 986 Billion (US$ 19.7 Billion) by FY 2014......
read more |
|
Buy Now
US$ 800.00
|
|
 |
| China Healthcare Sector Analysis |
| Apr, 2011 | Pages : 95 |
| The total healthcare expenditure in China is anticipated to grow strongly at a CAGR of around 16% during the forecast period (2011-2013), thus reaching Yuan 3 Trillion by 2013 end....
read more |
|
Buy Now
US$ 800.00 500.00
|
|
|
|
|
|
|
|
|
|
 |
|
|